Study Details
Design, interventions, and primary outcomes
About This Study
This trial studies the biospecimen and medical data collection in creating a research tissue registry in patients with inflammatory or invasive breast cancer. Collecting medical data and storing samples of blood, tissue, and stool from patients with inflammatory breast cancer to study in the laboratory may help doctors find better ways to treat and study inflammatory breast cancer in the future.
Design
Interventions / Regimen
- Procedure: Biospecimen Collection — Undergo collection of blood, tissue, and stool
- Other: Interview — Participate in interview
- Other: Medical Chart Review — Undergo collection of medical data
- Other: Questionnaire Administration — Ancillary Studies
Primary Outcomes
- Data, serum, tissue, peripheral blood mononuclear cells, and plasma sample collection (Up to 2 years)
Phase: Not Applicable
Status: Recruiting
Start Date: 2007-04-17
Completion: 2030-04-30
Sex: ALL
Volunteers: false
Enrollment: 1200 (ESTIMATED)
Collaborators: National Cancer Institute (NCI), Texas Appropriation for Rare and Aggressive diseases
- VIcente Valero, MD (PRINCIPAL_INVESTIGATOR) - M.D. Anderson Cancer Center
- Procedure: Biospecimen Collection — Undergo collection of blood, tissue, and stool
- Other: Interview — Participate in interview
- Other: Medical Chart Review — Undergo collection of medical data
- Other: Questionnaire Administration — Ancillary Studies